These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 16629491)
21. The serological response to Verocytotoxigenic Escherichia coli in patients with haemolytic uraemic syndrome. Chart H; Perry NT Lett Appl Microbiol; 2004; 38(5):351-4. PubMed ID: 15059202 [TBL] [Abstract][Full Text] [Related]
22. Analysis of saliva for antibodies to the LPS of Escherichia coli O157 in patients with serum antibodies to E. coli O157 LPS. Chart H; Perry NT; Willshaw GA; Cheasty T J Med Microbiol; 2003 Jul; 52(Pt 7):569-572. PubMed ID: 12808078 [TBL] [Abstract][Full Text] [Related]
23. Development and evaluation of latex agglutination tests for the detection of human antibodies to the lipopolysaccharides of verocytotoxin-producing Escherichia coli (VTEC) serogroups O157 and non-O157. Rastawicki W; Chróst A; Gielarowiec K J Microbiol Methods; 2017 Sep; 140():74-76. PubMed ID: 28732694 [TBL] [Abstract][Full Text] [Related]
24. New system for multilocus variable-number tandem-repeat analysis of the enterohemorrhagic Escherichia coli strains belonging to three major serogroups: O157, O26, and O111. Izumiya H; Pei Y; Terajima J; Ohnishi M; Hayashi T; Iyoda S; Watanabe H Microbiol Immunol; 2010 Oct; 54(10):569-77. PubMed ID: 21118294 [TBL] [Abstract][Full Text] [Related]
25. Outbreak of Enterohemorrhagic Escherichia coli O157:H7 Infection Associated with Minced Meat Cutlets Consumption in Kanagawa, Japan. Furukawa I; Suzuki M; Masaoka T; Nakajima N; Mitani E; Tasaka M; Teranishi H; Matsumoto Y; Koizumi M; Ogawa A; Oota Y; Homma S; Sasaki K; Satoh H; Sato K; Muto S; Anan Y; Kuroki T Jpn J Infect Dis; 2018 Nov; 71(6):436-441. PubMed ID: 30068886 [TBL] [Abstract][Full Text] [Related]
26. Microevolution of epidemiological highly relevant non-O157 enterohemorrhagic Escherichia coli of serogroups O26 and O111. Eichhorn I; Semmler T; Mellmann A; Pickard D; Anjum MF; Fruth A; Karch H; Wieler LH Int J Med Microbiol; 2018 Dec; 308(8):1085-1095. PubMed ID: 30115547 [TBL] [Abstract][Full Text] [Related]
31. Antibody responses to Escherichia coli O157 and other lipopolysaccharides in healthy children and adults. Navarro A; Eslava C; Hernandez U; Navarro-Henze JL; Aviles M; Garcia-de la Torre G; Cravioto A Clin Diagn Lab Immunol; 2003 Sep; 10(5):797-801. PubMed ID: 12965907 [TBL] [Abstract][Full Text] [Related]
32. Fecal diagnostics in combination with serology: best test to establish STEC-HUS. Wijnsma KL; van Bommel SA; van der Velden T; Volokhina E; Schreuder MF; van den Heuvel LP; van de Kar NC Pediatr Nephrol; 2016 Nov; 31(11):2163-70. PubMed ID: 27240858 [TBL] [Abstract][Full Text] [Related]
33. [Development of an enzyme-linked immunosorbent assay (ELISA) for detection of IgM and IgG antibodies to lipopolysaccharide of Escherichia coli O157]. Sugawara N; Saika T; Hasegawa M; Kobayashi I; Kurimoto F; Takeda T Kansenshogaku Zasshi; 1999 Jun; 73(6):593-9. PubMed ID: 10423950 [TBL] [Abstract][Full Text] [Related]
34. New perspectives on the role of Escherichia coli O157:H7 and other enterohaemorrhagic E. coli serotypes in human disease. Goldwater PN; Bettelheim KA J Med Microbiol; 1998 Dec; 47(12):1039-45. PubMed ID: 9856639 [TBL] [Abstract][Full Text] [Related]
35. [Epidemiological and bacteriological investigation of enterohemorrhagic Escherichia coli infection in the Chugoku-Shikoku area]. Tanaka H; Tanio S; Hoshina T; Tomita M; Nakajima H; Sakaki M; Kawamoto S; Simizu T; Sunahara C; Yasuoka T; Inouye H; Watanabe H Kansenshogaku Zasshi; 2002 Jun; 76(6):439-49. PubMed ID: 12136652 [TBL] [Abstract][Full Text] [Related]
36. Evidence of persisting serum antibodies to Escherichia coli O157 lipopolysaccharide and Verocytotoxin in members of rural communities in England. Evans J; Chalmers RM; Chart H; Salmon RL; Kench SM; Coleman TJ; Meadows D; Morgan-Capner P; Softley P; Sillis M; Thomas DR Eur J Epidemiol; 2000; 16(10):885-9. PubMed ID: 11338118 [TBL] [Abstract][Full Text] [Related]
37. Vaccination with killed whole-cells of Escherichia coli O157:H7 hha mutant emulsified with an adjuvant induced vaccine strain-specific serum antibodies and reduced E. coli O157:H7 fecal shedding in cattle. Sharma VK; Schaut RG; Loving CL Vet Microbiol; 2018 Jun; 219():190-199. PubMed ID: 29778196 [TBL] [Abstract][Full Text] [Related]
38. Adhesion of enterohemorrhagic Escherichia coli O157:H7 to the intestinal epithelia is essential for inducing secretory IgA antibody production in the intestine of mice. Nagano K; Taguchi K; Tokoro S; Tatsuno I; Mori H Biol Pharm Bull; 2014; 37(3):409-16. PubMed ID: 24583860 [TBL] [Abstract][Full Text] [Related]
39. Epidemiological studies of coincidental outbreaks of enterohemorrhagic Escherichia coli O157:H7 infection and infectious gastroenteritis in Niimi City. Tsumagari K; Yamamoto H; Suganuma N; Kato M; Ikeda S; Imai K; Kira S; Taketa K Acta Med Okayama; 2000 Dec; 54(6):265-73. PubMed ID: 11132920 [TBL] [Abstract][Full Text] [Related]
40. Vaccination with DNA Encoding Truncated Enterohemorrhagic Escherichia coli (EHEC) Factor for Adherence-1 Gene (efa-1') Confers Protective Immunity to Mice Infected with E. coli O157:H7. Riquelme-Neira R; Rivera A; Sáez D; Fernández P; Osorio G; del Canto F; Salazar JC; Vidal RM; Oñate A Front Cell Infect Microbiol; 2015; 5():104. PubMed ID: 26835434 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]